BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

334 related articles for article (PubMed ID: 21750147)

  • 1. Aurintricarboxylic acid promotes the conversion of naive CD4+CD25- T cells into Foxp3-expressing regulatory T cells.
    Lim DG; Park YH; Kim SE; Kim YH; Park CS; Kim SC; Park CG; Han DJ
    Int Immunol; 2011 Sep; 23(9):583-92. PubMed ID: 21750147
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identification and characterization of Foxp3(+) gammadelta T cells in mouse and human.
    Kang N; Tang L; Li X; Wu D; Li W; Chen X; Cui L; Ba D; He W
    Immunol Lett; 2009 Aug; 125(2):105-13. PubMed ID: 19539651
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Conversion of peripheral CD4+CD25- naive T cells to CD4+CD25+ regulatory T cells by TGF-beta induction of transcription factor Foxp3.
    Chen W; Jin W; Hardegen N; Lei KJ; Li L; Marinos N; McGrady G; Wahl SM
    J Exp Med; 2003 Dec; 198(12):1875-86. PubMed ID: 14676299
    [TBL] [Abstract][Full Text] [Related]  

  • 4. TGF-beta1 modulates Foxp3 expression and regulatory activity in distinct CD4+ T cell subsets.
    Pyzik M; Piccirillo CA
    J Leukoc Biol; 2007 Aug; 82(2):335-46. PubMed ID: 17475784
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Activin a promotes the TGF-beta-induced conversion of CD4+CD25- T cells into Foxp3+ induced regulatory T cells.
    Huber S; Stahl FR; Schrader J; Lüth S; Presser K; Carambia A; Flavell RA; Werner S; Blessing M; Herkel J; Schramm C
    J Immunol; 2009 Apr; 182(8):4633-40. PubMed ID: 19342638
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Foxp3 expression in melanoma cells as a possible mechanism of resistance to immune destruction.
    Niu J; Jiang C; Li C; Liu L; Li K; Jian Z; Gao T
    Cancer Immunol Immunother; 2011 Aug; 60(8):1109-18. PubMed ID: 21547596
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CD4+Foxp3+ regulatory T cells converted by rapamycin from peripheral CD4+CD25(-) naive T cells display more potent regulatory ability in vitro.
    Chen JF; Gao J; Zhang D; Wang ZH; Zhu JY
    Chin Med J (Engl); 2010 Apr; 123(7):942-8. PubMed ID: 20497692
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Natural killer cells prevent CD28-mediated Foxp3 transcription in CD4+CD25- T lymphocytes.
    Brillard E; Pallandre JR; Chalmers D; Ryffel B; Radlovic A; Seilles E; Rohrlich PS; Pivot X; Tiberghien P; Saas P; Borg C
    Exp Hematol; 2007 Mar; 35(3):416-25. PubMed ID: 17309822
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The effect of immunosuppressive drug rapamycin on regulatory CD4+CD25+Foxp3+T cells in mice.
    Qu Y; Zhang B; Zhao L; Liu G; Ma H; Rao E; Zeng C; Zhao Y
    Transpl Immunol; 2007 Apr; 17(3):153-61. PubMed ID: 17331841
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Induction of IL-10+ CD4+ CD25+ regulatory T cells with decreased NF-κB expression during immunotherapy.
    Tsai YG; Chiou YL; Chien JW; Wu HP; Lin CY
    Pediatr Allergy Immunol; 2010 Feb; 21(1 Pt 2):e166-73. PubMed ID: 19682278
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Bacterial heat shock protein 60, GroEL, can induce the conversion of naïve T cells into a CD4 CD25(+) Foxp3-expressing phenotype.
    Ohue R; Hashimoto K; Nakamoto M; Furukawa Y; Masuda T; Kitabatake N; Tani F
    J Innate Immun; 2011; 3(6):605-13. PubMed ID: 21893964
    [TBL] [Abstract][Full Text] [Related]  

  • 12. CTLA4-Ig modifies dendritic cells from mice with collagen-induced arthritis to increase the CD4+CD25+Foxp3+ regulatory T cell population.
    Ko HJ; Cho ML; Lee SY; Oh HJ; Heo YJ; Moon YM; Kang CM; Kwok SK; Ju JH; Park SH; Park KS; Kim HY
    J Autoimmun; 2010 Mar; 34(2):111-20. PubMed ID: 19665867
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Protein kinase B/Akt signals impair Th17 differentiation and support natural regulatory T cell function and induced regulatory T cell formation.
    Pierau M; Engelmann S; Reinhold D; Lapp T; Schraven B; Bommhardt UH
    J Immunol; 2009 Nov; 183(10):6124-34. PubMed ID: 19841181
    [TBL] [Abstract][Full Text] [Related]  

  • 14. CD4(+) CD25(low) GITR(+) cells: a novel human CD4(+) T-cell population with regulatory activity.
    Bianchini R; Bistoni O; Alunno A; Petrillo MG; Ronchetti S; Sportoletti P; Bocci EB; Nocentini G; Gerli R; Riccardi C
    Eur J Immunol; 2011 Aug; 41(8):2269-78. PubMed ID: 21557210
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Expansion of CD4(+)CD25 (+) regulatory T cells from cord blood CD4(+) cells using the common γ-chain cytokines (IL-2 and IL-15) and rapamycin.
    Asanuma S; Tanaka J; Sugita J; Kosugi M; Shiratori S; Wakasa K; Shono Y; Shigematsu A; Kondo T; Kobayashi T; Asaka M; Imamura M
    Ann Hematol; 2011 Jun; 90(6):617-24. PubMed ID: 21107839
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sub-optimal CD4+ T-cell activation triggers autonomous TGF-β-dependent conversion to Foxp3+ regulatory T cells.
    Oliveira VG; Caridade M; Paiva RS; Demengeot J; Graca L
    Eur J Immunol; 2011 May; 41(5):1249-55. PubMed ID: 21469093
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tolerogenic dendritic cells induce CD4+CD25hiFoxp3+ regulatory T cell differentiation from CD4+CD25-/loFoxp3- effector T cells.
    Huang H; Dawicki W; Zhang X; Town J; Gordon JR
    J Immunol; 2010 Nov; 185(9):5003-10. PubMed ID: 20870943
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Transforming growth factor-beta and all-trans retinoic acid generate ex vivo transgenic regulatory T cells with intestinal homing receptors.
    Moore C; Sauma D; Morales J; Bono MR; Rosemblatt M; Fierro JA
    Transplant Proc; 2009; 41(6):2670-2. PubMed ID: 19715998
    [TBL] [Abstract][Full Text] [Related]  

  • 19. CTLA-4 x Ig converts naive CD4+CD25- T cells into CD4+CD25+ regulatory T cells.
    Razmara M; Hilliard B; Ziarani AK; Chen YH; Tykocinski ML
    Int Immunol; 2008 Apr; 20(4):471-83. PubMed ID: 18272926
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Forced overexpression of either of the two common human Foxp3 isoforms can induce regulatory T cells from CD4(+)CD25(-) cells.
    Aarts-Riemens T; Emmelot ME; Verdonck LF; Mutis T
    Eur J Immunol; 2008 May; 38(5):1381-90. PubMed ID: 18412171
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.